Boston Therapeutics Obtains Financing for International Trial

Boston Therapeutics announced the complete funding for a new BTI320 trial on type 2 diabetic patients.

Boston Therapeutics Announces Innovation Grant

Today Boston Therapeutics and Advance Pharmaceutical, which holds a license for the Company's products in Asia, are announcing another advancement...